UK guidance on insulin pumps updated

The UK's National Institute for Health and Clinical Excellence (NICE) has updated its guidance on continuous subcutaneous insulin pump therapy, recommending it as a possible treatment for adults and children 12 years and over with type 1 diabetes if attempts to reach target HbA1c levels with multiple daily injections result in the person having disabling hypoglycemia.

The treatment is also recommended for patients whose HbA1c levels have remained high (8.5% or above) with multiple daily injections, including using long-acting insulin analogs if appropriate. Insulin pump therapy is recommended as a possible treatment for children under 12